| Symbol | XERS |
|---|---|
| Name | XERIS BIOPHARMA HOLDINGS, INC. |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Address | Illinois, 60607, United States |
| Telephone | 844-445-5704 |
| Fax | — |
| — | |
| Website | https://www.xerispharma.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001867096 |
| Description | Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies in Illinois. The company markets Gvoke, a ready-to-use liquid-stable glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, hypokalemic, and related variants of primary periodic paralysis; and Recorlev, a cortisol synthesis inhibitor proved for the treatment of endogenous hypercortisolemia in adult patients with Cushings syndrome. It also has a pipeline of development programs to extend the marketed products into new indications and uses and bring new products using its proprietary formulation technology platforms, XeriSol and XeriJect. The company was incorporated in 2005 and is headquartered in Chicago, Illinois. Additional info from NASDAQ: |
Pieper Steven 🔴 sold 5.0K shares of Xeris Biopharma Holdings, Inc. (XERS) at $8.50 Transaction Date: Aug 12, 2026 | Filing ID: 000009
Read more📋 STEVEN PIEPER (Officer) plans to sell 20K shares of XERIS BIOPHARMA HOLDINGS INC (at $8.39 each, total $168K) Filed: Aug 12, 2026 | ID: 008033
Read moreNew Form SCHEDULE 13G - Xeris Biopharma Holdings, Inc. <b>Filed:</b> 2026-07-31 <b>AccNo:</b> 0002100119-26-001430 <b>Size:</b> 7 KB
Read moreXeris Biopharma to Report Second Quarter 2026 Financial Results on August 6, 2026
Read more(99% Neutral) XERIS BIOPHARMA HOLDINGS, INC. (XERS) Provides Business Update
Read morePieper Steven 🔴 sold 45.0K shares of Xeris Biopharma Holdings, Inc. (XERS) at $8.52 Transaction Date: Jul 06, 2026 | Filing ID: 000007
Read more📋 STEVEN PIEPER (Officer) plans to sell 28K shares of XERIS BIOPHARMA HOLDINGS, INC. (at $8.37 each, total $231K) Filed: Jul 07, 2026 | ID: 006941
Read more📋 STEVEN PIEPER (Officer) plans to sell 17K shares of XERIS BIOPHARMA HOLDINGS, INC. (at $8.28 each, total $144K) Filed: Jul 06, 2026 | ID: 006884
Read moreCORRECTING and REPLACING Xeris Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Read more